Magic mushrooms and toad venom

Psychedelic drugs such as psilocybin (found in “magic mushrooms”) and 5-MeO-DMT (a compound derived from toad venom) are being tested for treating cases of depression that don’t respond to standard treatments. New depression approaches are needed since current treatments don’t work in nearly half of patients. Hallucinogenics may change longstanding thought patterns or promote new connections in brain neurons. Benefits of psilocybin on mood appear to be long-lasting. FDA approval for psilocybin will likely take several more years.